Statistics from Altmetric.com
We have been offering subcutaneous micronised depot medroxyprogesterone acetate (Sayana Press) (DMPA-SC) as an option to women already using the injectable contraceptive, DepoProvera (DMPA-IM) for the last 18 months. To date we have 23 women who are self-administering Sayana Press.
One woman, a healthcare professional used to giving injections and one of our earliest Sayana Press users, reported a significant degree of soreness at the injection site at her annual review in December 2017. She described each site as being acutely tender, even to light touch, …
Contributors There are no other contributors.
Competing interests None declared.
Patient consent Obtained.
Provenance and peer review Not commissioned; internally peer reviewed.
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.